Genetic Aspects of Conjunctival Melanoma: A Review
Open Access
Abstract
Conjunctival melanoma (CM) is a rare but aggressive cancer. Over the past decade, molecular studies using rapidly advancing technologies have increasingly improved our understanding of CM genetics. CMs are mainly characterized by dysregulated MAPK and PI3K/AKT/mTOR pathways, driven by commonly mutated (BRAF, NRAS, NF1) or less commonly mutated (KIT, PTEN) genes. Another group of genes frequently mutated in CMs include TERT and ATRX, with known roles in telomere maintenance and chromatin remodeling/epigenetic regulation. Uveal melanoma-related genes (BAP1, SF3B1, GNAQ/11) can also be mutated in CMs, albeit infrequently. Additional CM-related mutated genes have increasingly been identified using more comprehensive genetic analyses, awaiting further confirmation in additional/larger studies. As a tumor arising in a partly sun-exposed mucosal tissue, CM exhibits a distinct genomic profile, including the frequent presence of an ultraviolet (UV) signature (and high mutational load) and also the common occurrence of large structural variations (distributed across the genome) in addition to specific gene mutations. The knowledge gained from CM genetic studies to date has led to new therapeutic avenues, including the use of targeted and/or immuno-therapies with promising outcomes in several cases. Accordingly, the implementation of tumor genetic testing into the routine clinical care of CM patients holds promise to further improve and personalize their treatments. Likewise, a growing knowledge of poor prognosis-associated genetic changes in CMs (NRAS, TERT, and uveal melanoma signature mutations and chromosome 10q deletions) may ultimately guide future strategies for prognostic testing to further improve clinical outcomes (by tailoring surveillance and considering prophylactic treatments in patients with high-risk primary tumors).Keywords
Funding Information
- Richard N
- Marilyn K Witham
This publication has 106 references indexed in Scilit:
- Deciphering Signatures of Mutational Processes Operative in Human CancerCell Reports, 2013
- KIT mutations in ocular melanoma: frequency and anatomic distributionLaboratory Investigation, 2011
- Multiplex Ligation-Dependent Probe Amplification of Conjunctival Melanoma Reveals CommonBRAFV600E Gene Mutation and Gene Copy Number ChangesInvestigative Ophthalmology & Visual Science, 2011
- Conjunctival MelanomaOphthalmology, 2011
- Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanomaMelanoma Research, 2010
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Population-Based Incidence of Conjunctival Melanoma in Various Races and Ethnic Groups and Comparison With Other MelanomasAmerican Journal of Ophthalmology, 2008
- T1799ABRAFMutations in Conjunctival Melanocytic LesionsInvestigative Ophthalmology & Visual Science, 2005
- Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumorsOphthalmology, 2004
- BRAFMutations in Conjunctival MelanomaInvestigative Ophthalmology & Visual Science, 2004